close read more

Servier, committed to fight climate change

An ambitious low carbon strategy

Read the insight

Home - Servier

logo twitter

Employees in  66 countries,
including  5,000 in France.

100 million

patients treated each day worldwide with Servier medicines.

25 %

of revenue from brand-name medicines invested in R&D each year on average.

4.6 billion

euros in revenue in 2018/2019 comprising €3.2 billion for brand-name medicines and €1.4 billion for generic medicines.

5 therapeutic areas

cardiovascular, cancer, diabetes immune-inflammatory and neuropsychiatric diseases.

icon play
icon play

Join our teams!

We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Global warming: the Servier strategy validated by the SBTi

Servier reaffirms its commitment thanks to the “Servier Climate Commitment” project validated by the Science Based Targets initiative, a recognized international organization and expert in greenhouse gas emission reduction trajectories.

2019 CSR Report

The report underlines the contribution of CSR to the Group’s performance. It also illustrates Servier’s commitment to a structured and value creating CSR approach.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.

icon play